You are viewing: Mexico Nuclear Medicine Equipment Market analysis

The Mexico Nuclear Medicine Equipment Market was valued at $60.3 Million in 2025 and projected to reach to $71.1 Million by 2030, representing a compound annual growth rate of 3.3%. Mexico's nuclear medicine equipment market is positioned for steady growth through 2030, driven by healthcare modernization efforts and increased diagnostic imaging adoption across the country.

Mexico Nuclear Medicine Equipment Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Mexico Nuclear Medicine Equipment Market Trends and Insights

  • This steady expansion reflects Mexico's increasing investment in diagnostic imaging infrastructure and healthcare modernization across both public and private sectors.
  • Mexico's market growth is driven by rising prevalence of chronic diseases, expanding access to advanced diagnostic technologies, and government initiatives to strengthen healthcare delivery systems. The nuclear medicine equipment sector in Mexico is characterized by gradual adoption of SPECT and PET imaging systems, particularly in major urban centers and specialized medical facilities.
  • Mexico's market trajectory through 2030 demonstrates sustained demand for diagnostic imaging solutions, supported by growing patient populations requiring oncology, cardiology, and neurology imaging services.
  • Key challenges include equipment costs, regulatory compliance, and the need for specialized technical expertise, which continue to shape Mexico's market dynamics and investment patterns in nuclear medicine technology..

Key Market Statistics

  • CAGR (2025-2030) 3.3% CAGR
  • Market Size, 2025 ~USD 60.3 Million
  • Forecast, 2030 ~USD 71.1 Million
  • Country Mexico

Mexico Nuclear Medicine Equipment Market Overview

Market Valuation :

Mexico's nuclear medicine equipment market is valued at USD 60.3 million in 2025, with projected growth to USD 71.1 million by 2030, demonstrating steady market expansion.

Growth Rate :

The Mexican market is growing at a CAGR of 3.3% through 2030, slightly below the global average of 4.62%, reflecting a more conservative but stable growth trajectory.

Healthcare Infrastructure Investment :

Mexico's market expansion is driven by increasing investment in diagnostic imaging infrastructure and healthcare modernization initiatives across both public and private healthcare sectors.

Sector Diversification :

Growth is supported by rising demand from both government-funded healthcare systems and private medical institutions seeking advanced nuclear medicine diagnostic capabilities.

Mexico Nuclear Medicine Equipment Market Dynamics

  • The Mexican government's commitment to upgrading public healthcare infrastructure, combined with growing private sector investments, creates sustained demand for advanced nuclear medicine technologies.
  • Public hospitals and private clinics are increasingly recognizing the clinical value of nuclear medicine diagnostics, particularly in oncology and cardiology applications. The market's 3.3% CAGR reflects Mexico's measured but consistent healthcare advancement.
  • Key growth catalysts include rising healthcare expenditures, improved reimbursement policies, and expanding access to diagnostic services in both urban and emerging regional markets.
  • As Mexico continues to strengthen its healthcare capabilities and address diagnostic imaging gaps, nuclear medicine equipment adoption is expected to accelerate, particularly among mid-sized hospitals and specialized diagnostic centers seeking cost-effective imaging solutions..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • SANOFI
  • Pfizer Inc.
  • NOVARTIS

    Key Takeaways

    • Mexico's nuclear medicine equipment market is valued at USD 60.3 million in 2025 and will reach USD 71.1 million by 2030 at a 3.3% CAGR.
    • Mexico's market growth is driven by rising chronic disease prevalence and government healthcare modernization initiatives.
    • SPECT and PET imaging systems are gradually gaining adoption in Mexico's major urban medical centers and specialized facilities.
    • Mexico faces market challenges including high equipment costs, regulatory compliance requirements, and shortage of specialized technical expertise.

    Nuclear Medicine Equipment Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment DIAGNOSTIC IMAGING CENTERS (End User)
    Forecast Period 2025–2030
    Growth Rate CAGR of 4.62% from 2025 to 2030
    Largest Segment IMAGING MODALITIES (System Type)
    Market Size Base Year (Billions) ~USD 6.63 (2025)
    Revenue Forecast (Billions) ~USD 8.31 (2030)
    Segments Covered System Type, Type, Therapeutic Area, Dimension, End User, Type 2023–2030

    Mexico Nuclear Medicine Equipment Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By System Type

    • Imaging Modalities
    • Non- Imaging Modalities
    • Non-Imaging Modalities

    By Type

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gamma/Scintillation Cameras
    • Gm Counters
    • Hybrid Pet
    • Hybrid Spect
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect
    • Standalone Pet
    • Standalone Spect

    By Therapeutic Area

    • Cardiology
    • Neurology
    • Oncology
    • Orthopedics
    • Other Therapeutic Areas
    • Thyroid

    By Dimension

    • 2D
    • 3D

    By End User

    • Cancer Treatment Centers
    • Diagnostic Imaging Centers
    • Hospitals
    • Other End Users

    By Type 2023–2030

    • Dose Calibrators
    • Gamma Well Counters
    • Gamma/ Scintillation Cameras
    • Gm Counters
    • Other Non-Imaging Modalities
    • Pet
    • Probe Counting Systems
    • Spect

    MEXICO: NUCLEAR MEDICINE EQUIPMENT MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    CANCER TREATMENT CENTERS8.48.79.19.49.810.110.510.93.7
    DIAGNOSTIC IMAGING CENTERS12.51313.514.114.615.215.816.44
    HOSPITALS30.131.132.133.234.235.336.437.53.1
    OTHER END USERS5.35.45.65.75.966.16.32.5
    TOTAL56.358.360.362.364.566.668.871.13.3

    Target Audience

    • Medical Device Manufacturers : Manufacturers of nuclear medicine equipment need Mexico-specific market data to assess market potential, develop localized product strategies, and identify distribution partnerships in this growing healthcare market.
    • Healthcare Investors : Private equity firms and healthcare investors require detailed market analysis to evaluate investment opportunities in Mexico's diagnostic imaging and nuclear medicine sectors.
    • Hospital and Clinic Operators : Healthcare facility administrators need market insights to justify capital investments in nuclear medicine equipment and understand competitive positioning within Mexico's healthcare landscape.
    • Distributors and Resellers : Medical equipment distributors and resellers need Mexico-specific demand forecasts and market dynamics to optimize inventory, plan sales strategies, and identify growth opportunities.
    • Healthcare Consultants : Management consultants and healthcare advisors require validated market data to support client recommendations on healthcare technology investments and market expansion strategies in Mexico.

    Key Companies in the Mexico Nuclear Medicine Equipment Market

    CompanyHQOwnershipStrongest segments
    PHILIPSNetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma),Software (Image Management, PACS, Treatment, Analytics, Workflow),Detectors & Counters (GM Counter, Dose Calibrator and Related),
    DIGIRAD CORPORATIONUnited StatesPrivate CompanyImaging – SPECT / Gamma cameras,Imaging – PET,Radiation detection (GM counters, dose calibrators),
    TOSHIBA CORPORATIONJapanPrivate CompanyImaging Equipment (PET, SPECT, Gamma),Radiation Measurement (GM Counter, Dose Calibrator),Software (Image Management, PACS, Treatment, Analytic, Workflow),
    SIEMENS AGGermanyPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Treatment, Analytics, Workflow),Therapy-adjacent Solutions (Onco, Cardio, Neuro, Ortho Planning/Support),
    GE HEALTHCAREUnited StatesPublic CompanyImaging – PET,Imaging – SPECT,Imaging – Gamma cameras,
    SIEMENS HEALTHINEERS AGGermany
    KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyImaging Systems (PET, SPECT, Gamma Cameras),Software (Image Management, PACS, Analytics, Workflow, Treatment Planning Interfaces),Therapy-related Applications (Oncology, Cardiology, Neurology, Orthopedic Planning),
    MIRION TECHNOLOGIES, INC.United StatesPublic CompanyImaging-related equipment (PET/SPECT/Gamma-adjacent QA, detectors, cameras),Radiation measurement & counters (GM counters, dose calibrators, health-physics),Software (image/spectroscopy analysis, QA, workflow, treatment support),
    DOSISOFT SAFrancePrivate CompanyImaging-related software (PET/SPECT/Gamma image management & PACS integration),Treatment planning & dosimetry software (Onco/Cardio/Neuro/Ortho),Analytics & workflow orchestration,
    SEGAMI CORPORATIONJapanPrivate CompanyImaging Equipment (PET/SPECT/Gamma),GM Counters & Dose Calibrators,Nuclear Medicine Software (Image Management, PACS, Treatment, Analytic, Workflow),
    LABLOGIC SYSTEMS LTD.United KingdomPrivate CompanyImaging-adjacent QC hardware (gamma counters, dose calibrator-related QC, radiochromatography hardware),CDS / Image & data management software for radiopharmaceutical workflows,LIMS / workflow and analytic software for nuclear medicine and radiochemistry labs,

    PHILIPS

    Philips is a Dutch multinational public company founded in 1891 with 63,670 employees. The company operates across healthcare, consumer lifestyle, and lighting sectors.

    DIGIRAD CORPORATION

    Digirad Corporation is a United States-based private company founded in 1985 with 194 employees.

    TOSHIBA CORPORATION

    Toshiba Corporation is a Japanese private company founded in 1875 with 106,648 employees, operating across multiple industrial and technology sectors.

    SIEMENS AG

    Siemens AG is a German public company founded in 1847 with 310,312 employees, operating across industrial, infrastructure, and healthcare sectors.

    GE HEALTHCARE

    GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.

    SIEMENS HEALTHINEERS AG

    Siemens Healthineers AG is a German healthcare company within the Siemens group.

    KONINKLIJKE PHILIPS N.V.

    Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 63,670 employees, operating across healthcare, consumer lifestyle, and lighting sectors.

    MIRION TECHNOLOGIES, INC.

    Mirion Technologies, Inc. is a United States-based public company founded in 2005 with 3,281 employees.

    DOSISOFT SA

    Dosisoft SA is a French private company founded in 2002.

    SEGAMI CORPORATION

    Segami Corporation is a Japanese private company with 1,501 employees.

    LABLOGIC SYSTEMS LTD.

    Lablogic Systems Ltd. is a United Kingdom-based private company founded in 1980.

    Reasons to Buy this Report

    • Market Entry Strategy : Understand Mexico's specific market dynamics, growth drivers, and competitive landscape to develop targeted market entry strategies and localized business plans for nuclear medicine equipment distribution.
    • Investment Decision Support : Access validated market sizing and forecast data to support investment decisions, capital allocation, and partnership opportunities in Mexico's healthcare technology sector.
    • Competitive Positioning : Identify market gaps, customer preferences, and regional demand patterns specific to Mexico to position products and services competitively against local and international competitors.
    • Regulatory and Sector Insights : Gain insights into Mexico's healthcare modernization priorities, public-private sector dynamics, and institutional procurement patterns to align offerings with market needs.
    • Growth Opportunity Identification : Leverage detailed market analysis to identify high-potential customer segments, geographic expansion opportunities, and emerging demand drivers within Mexico's nuclear medicine sector.

    Frequently asked questions

    What is the current size of Mexico's nuclear medicine equipment market?

    Mexico's nuclear medicine equipment market is valued at USD 60.3 million in 2025.

    What is the projected market size for Mexico by 2030?

    Mexico's nuclear medicine equipment market is projected to reach USD 71.1 million by 2030.

    What is the growth rate of Mexico's nuclear medicine equipment market?

    Mexico's nuclear medicine equipment market is expected to grow at a CAGR of 3.3% from 2025 to 2030.

    What are the main drivers of growth in Mexico's nuclear medicine equipment market?

    Mexico's market growth is primarily driven by rising chronic disease prevalence, healthcare infrastructure modernization, and increased demand for advanced diagnostic imaging in oncology, cardiology, and neurology applications.

    What challenges does Mexico's nuclear medicine equipment market face?

    Mexico's market faces challenges including high equipment acquisition costs, complex regulatory compliance requirements, limited availability of specialized technical expertise, and infrastructure limitations in non-urban regions.

    RESEARCH METHODOLOGY

    This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the nuclear medicine equipment market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the nuclear medicine equipment market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the World Health Organization (WHO), the Organisation for Economic Co-operation and Development (OECD), Healthcare Information and Management Systems Society (HIMSS), Centers for Disease Control and Prevention (CDC), ClinicalTrials.gov, Expert Interviews, and MarketsandMarkets Analysis.

    Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the nuclear medicine equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends, to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

    Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

    After completing the market engineering process, which includes calculations for market statistics, market breakdown, size estimations, forecasting, and data triangulation, extensive primary research was conducted. This research aimed to gather information and verify the critical numbers obtained during the market analysis. Additionally, primary research was conducted to identify different types of market segmentation, analyze industry trends, evaluate the competitive landscape of nuclear medicine equipment offered by various players, and understand key market dynamics such as drivers, restraints, opportunities, challenges, industry trends, and strategies employed by key market participants.

    In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

    Breakdown of Primary Interviews

    Nuclear Medicine Equipment Market

    Note 1: Other designations include sales, marketing, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue, as of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (revenue share analysis of leading players) and top-down approach (assessment of utilization/adoption/penetration trends, by product type, therapeutic area, dimension, end user, and region).

    Nuclear Medicine Equipment Market

    Data Triangulation

    After arriving at the overall market size, from the market size estimation process explained above, the nuclear medicine equipment market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the nuclear medicine equipment market.

    Market Definition

    Nuclear medicine equipment refers to specialized medical devices used to perform diagnostic and therapeutic procedures involving radioactive substances. These include imaging systems such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography) scanners, as well as gamma cameras and hybrid imaging systems. The equipment enables the detection, imaging, and tracking of radiopharmaceuticals within the body, playing a crucial role in disease diagnosis, monitoring, and targeted radionuclide therapy.

    Stakeholders

    • Nuclear Medicine Equipment Vendors & Imaging Device Manufacturers
    • Healthcare Providers (Hospitals, Outpatient Settings, Diagnostics & Imaging Centers, Radiopharmacies, Other Healthcare Providers)
    • Clinical Research Organizations (CROs)
    • Research & Development (R&D) Companies
    • Business Research & Consulting Service Providers
    • Medical Research Laboratories
    • Academic Medical Centers/Universities/Hospitals/Research Institutes
    • Regulatory Bodies (FDA, EMA, IAEA)
    • AI & Algorithm Developers
    • Venture Capitalists
    • Advocacy Groups
    • Investors & Financial Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Contract Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the nuclear medicine equipment market by product type, therapeutic area, dimension, end user, and region
    • To provide detailed information regarding the major drivers, restraints, opportunities, and challenges influencing market growth
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall nuclear medicine equipment market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the nuclear medicine equipment market in five main regions (and their respective countries): North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America
    • To provide key industry insights, such as supply chain, regulatory, patent, and recession impact analysis
    • To profile the key players in the market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches & upgrades, collaborations, partnerships, acquisitions, investments, contracts, agreements, alliances, mergers, funding, and expansions of the leading players in the market
    • To benchmark players within the market using the company evaluation matrix, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offering

    Get the Full Nuclear Medicine Equipment Market Report

    Full forecast, segment splits, and company analysis for all Nuclear Medicine Equipment Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status